1. Home
  2. QTRX vs CLDT Comparison

QTRX vs CLDT Comparison

Compare QTRX & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$6.34

Market Cap

306.0M

Sector

Industrials

ML Signal

HOLD

Logo Chatham Lodging Trust (REIT) of Beneficial Interest

CLDT

Chatham Lodging Trust (REIT) of Beneficial Interest

HOLD

Current Price

$7.67

Market Cap

362.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
CLDT
Founded
2007
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
306.0M
362.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
QTRX
CLDT
Price
$6.34
$7.67
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$11.33
$9.50
AVG Volume (30 Days)
534.0K
236.6K
Earning Date
04-03-2026
01-01-0001
Dividend Yield
N/A
4.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,632,000.00
N/A
Revenue This Year
N/A
$1.76
Revenue Next Year
$28.28
N/A
P/E Ratio
N/A
$610.21
Revenue Growth
64.52
N/A
52 Week Low
$4.15
$5.83
52 Week High
$8.77
$8.42

Technical Indicators

Market Signals
Indicator
QTRX
CLDT
Relative Strength Index (RSI) 50.85 58.60
Support Level $6.23 $6.63
Resistance Level $6.38 $7.74
Average True Range (ATR) 0.38 0.24
MACD 0.10 0.00
Stochastic Oscillator 62.02 54.07

Price Performance

Historical Comparison
QTRX
CLDT

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: